Skip to main content
  • EASTBOURNE Data Show ‘Encouraging’ Safety and Efficacy Profile for Novel Sirolimus-Coated Balloon at Mid-Term Follow-Up

    The novel MagicTouch sirolimus-coated balloon shows an “encouraging” safety and efficacy profile in a broad spectrum of coronary artery disease (CAD) patients, according to new data from the EASTBOURNE investigator-driven registry.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details